Ainos, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AIMD research report →
Companyainos.com
Ainos, Inc. , a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.
- CEO
- Chun-Hsien Tsai
- IPO
- 2021
- Employees
- 44
- HQ
- San Diego, CA, US
Price Chart
Valuation
- Market Cap
- $6.79M
- P/E
- -0.65
- P/S
- 375.00
- P/B
- 1.59
- EV/EBITDA
- -1.79
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -26296.83%
- Op Margin
- -72393.48%
- Net Margin
- -76996.25%
- ROE
- -160.55%
- ROIC
- -73.93%
Growth & Income
- Revenue
- $124.16K · 498.95%
- Net Income
- $-14,771,012 · 0.62%
- EPS
- $-3.46 · -121.79%
- Op Income
- $-13,990,408
- FCF YoY
- 20.25%
Performance & Tape
- 52W High
- $4.50
- 52W Low
- $1.26
- 50D MA
- $1.62
- 200D MA
- $2.41
- Beta
- 2.29
- Avg Volume
- 27.57K
Get TickerSpark's AI analysis on AIMD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 19, 26 | chiang yao-chung | buy | 2,200 |
| May 18, 26 | chiang yao-chung | buy | 500 |
| May 5, 26 | chiang yao-chung | buy | 129 |
| Apr 30, 26 | chiang yao-chung | buy | 200 |
| Apr 29, 26 | chiang yao-chung | buy | 100 |
| Apr 15, 26 | TSAI CHUN-JUNG | other | 330,000 |
| Apr 15, 26 | TSAI CHUN-JUNG | other | 330,000 |
| Apr 15, 26 | TSAI CHUN-JUNG | other | 330,000 |
| Apr 15, 26 | tsai chun-hsien | other | 300,000 |
| Apr 15, 26 | tsai chun-hsien | other | 300,000 |
Our AIMD Coverage
We haven't published any research on AIMD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AIMD Report →